EC Number   |
KM Value [mM] |
KM Value Maximum [mM] |
Substrate |
Reference |
|---|
   1.1.1.B40 | 0.0000044 |
- |
NAD+ |
reduction of corticosterone, pH and temperature not specified in the publication |
285951 |
| 1.1.1.B40 | 0.0000051 |
- |
11beta,21-dihydroxypregn-4-en-3,20-dione |
- |
285953 |
| 1.1.1.B40 | 0.0000102 |
- |
NAD+ |
kidney homogenate, pH and temperature not specified in the publication |
688766 |
| 1.1.1.B40 | 0.000012 |
- |
11beta,21-dihydroxypregn-4-en-3,20-dione |
- |
285957 |
| 1.1.1.B40 | 0.000014 |
- |
11beta,21-dihydroxypregn-4-en-3,20-dione |
isoform 11beta-HSD2 |
285948 |
| 1.1.1.B40 | 0.000047 |
- |
11beta,17,21-trihydroxy-pregn-4-ene-3,20-dione |
i.e. cortisol |
285953 |
| 1.1.1.B40 | 0.000047 |
- |
corticosterone |
37°C, in non-pregnant myometrium |
656372 |
| 1.1.1.B40 | 0.00006 |
- |
corticosterone |
37°C, after day 23 of pregnancy |
656372 |
| 1.1.1.B40 | 0.000075 |
- |
corticosterone |
37°C, after day 10 of pregnancy |
656372 |
| 1.1.1.B40 | 0.000084 |
- |
11beta,21-dihydroxypregn-4-en-3,20-dione |
temperature not specified in the publication, pH 5.5-6 |
285955 |
